Greenhill

GSK seeks mid-September bids for $4 billion Indian Horlicks unit, say sources

GSK started a strategic review of Horlicks - a malt-based drink brand popular in India – and some smaller products, after buying Novartis out of their consumer healthcare venture for $13 billion in March.